ARCHIVES

FDA Approves Lapatinib For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

AACR 2014 Cancer Progress Report: More Federal Funds Needed

September 19, 2014

BRM Phase 1-2 Task Orders Awarded

November 21, 1980

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

September 24, 1999

Nine More Reported In Range Of CCOP 3 Recompetition

February 2, 1990

Sen. Pryor Attacks Drug Industry, NIH Technology Transfer

March 5, 1993

Patient Groups Are Focus of New Alliances In a Shift of Cancer Advocacy Agenda

May 31, 1996